It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).
This page is not supported in mobiles. Please view it in the desktop version.
As patient care gets increasingly sophisticated and injectable medication delivery gets more complicated, so does the job you do. We can help you assess the options for optimizing your competitive position through parenteral delivery systems to achieve the commercial objectives for your product. There are many benefits of pursuing lifecycle strategies such as opening up new markets, extending patent life or gaining improved formulary placement while striving to improve patient and caregiver safety.
Key Finding 1: In a study of 75 marketing leaders of injectable therapies on lifecycle management, lifecycle management decisions are most often made jointly by R&D and Marketing1.
Key Finding 2: In addition, Respondents identified that partnering is an effective option for implementing Lifecycle Management strategies1:
Most Beneficial LCM Strategies View Larger
1. Research study commissioned by Baxter BioPharma Solutions with n=75 brand and marketing managers, December 2009.
Talk to us at these events